Finance

Lists
CAI:NASDAQ
Caris Life Sciences Inc
27,10 $
0,00%
(0,00) 1D
26,51 $
-2,18% (-0,59)
Pre-market
Closed: 7 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAI...
Mkt. cap
7,66 մլրդ
Avg. vol.
5,16 մլն
Volume
13,55 հզր
P/E ratio
73,86
52-wk high
33,65 $
52-wk low
14,19 $
EPS
0,37 $
Shares outstanding
282,60 մլն
No. of employees
2 հզր
Mkt. cap
7,66 մլրդ
Avg. vol.
5,16 մլն
Volume
13,55 հզր
P/E ratio
73,86
52-wk high
33,65 $
52-wk low
14,19 $
EPS
0,37 $
Shares outstanding
282,60 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
About Caris Life Sciences Inc
CEO-
Employees1,85 հզր
Founded2008
HeadquartersIrving, Տեխաս, Միացյալ Նահանգներ
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to CAI in the past 3 months
Buy
Buy
6
Hold
3
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for CAI in the last 3 months.
Highest
Current 27,10 $
35,00 $ (+29,15%)
Average
27,50 $ (+1,48%)
Lowest
21,00 $ (-22,51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evie Koslosky
Goldman Sachs
Buy
Maintained
35,00 $
+29,2%
09/20/2026
Unknown Analyst
UBS
Hold
Initiated
28,00 $
+3,3%
09/08/2026
Doug Schenkel
UBS
Hold
Initiated
28,00 $
+3,3%
09/09/2026
Mark Massaro
BTIG
Buy
Reiterated
33,00 $
+21,8%
08/07/2026
Michael Ryskin
Bank of America Securities
Buy
Maintained
-
-
08/06/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
25,00 $
-7,7%
08/06/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
26,00 $
-4,1%
08/06/2026
David Westenberg
Piper Sandler
Hold
Maintained
21,00 $
-22,5%
08/06/2026
Kyle Mikson CFA
Canaccord Genuity
Hold
Reiterated
22,00 $
-18,8%
08/06/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
30,00 $
+10,7%
07/15/2026
Michael Polark
Wolfe Research
Hold
Downgraded
-
-
06/01/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
36,00 $
+32,8%
05/11/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
22,00 $
-18,8%
05/08/2026
Patrick B Donnelly
Citi
Buy
Maintained
28,00 $
+3,3%
05/08/2026
Tycho Peterson
Jefferies
Buy
Initiated
28,00 $
+3,3%
04/12/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
/ 0,01 $
0,00%miss
Revenue / Est. (USD)
263,71 մլն / 238,08 մլն
+10,77%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
216,83 մլն
292,89 մլն
216,17 մլն
263,71 մլն
Cost of goods sold
69,33 մլն
70,10 մլն
74,83 մլն
84,12 մլն
Cost of revenue
69,33 մլն
70,10 մլն
74,83 մլն
84,12 մլն
Research and development expenses
21,62 մլն
29,82 մլն
31,32 մլն
32,36 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
93,24 մլն
104,55 մլն
104,75 մլն
120,31 մլն
Operating expense
114,86 մլն
134,37 մլն
136,07 մլն
152,67 մլն
Total operating expenses
184,19 մլն
204,48 մլն
210,89 մլն
236,79 մլն
Operating income
32,64 մլն
88,41 մլն
5,28 մլն
26,93 մլն
Other non operating income
-2,17 մլն
-148,00 հզր
49,00 հզր
101,00 հզր
EBT including unusual items
24,32 մլն
81,96 մլն
-644,00 հզր
-614,00 հզր
EBT excluding unusual items
24,32 մլն
83,92 մլն
-644,00 հզր
24,62 մլն
Income tax expense
-
-
-134,00 հզր
23,00 հզր
Effective tax rate
-
-
20,81%
-3,75%
Other operating expenses
-
-
-
-
Net income
24,32 մլն
81,96 մլն
-510,00 հզր
-637,00 հզր
Net profit margin
11,22%
27,98%
-0,24%
-0,24%
Earnings per share
0,08
0,28
-
-
Interest and investment income
7,36 մլն
7,02 մլն
6,83 մլն
6,82 մլն
Interest expense
-13,51 մլն
-11,36 մլն
-12,81 մլն
-9,23 մլն
Net interest expenses
-6,15 մլն
-4,34 մլն
-5,98 մլն
-2,41 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
37,51 մլն
92,70 մլն
10,35 մլն
33,46 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps